bioMérieux S.A.
bioMérieux S.A. (BMXMF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BMXMF · as of Jun 9, 2026
Key Statistics
Explore bioMérieux S.A. Data
bmxmf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 80.0%
Competitors & Peers
bmxmf competitorsBMXMF
A
APDN
CDNA
CRL
DHRStock Performance
Full HistoryAbout bioMérieux S.A.
bioMérieux S.A. Operating on a global scale, bioMérieux S.A. designs and produces in vitro diagnostic solutions specifically for detecting infectious diseases across the Americas, Europe, the Middle East, Africa, and…
what is biomérieux s.a. · bmxmf stock overview · biomérieux s.a. company profile · who is biomérieux s.a. ceo · bmxmf OTC · biomérieux s.a. headquarters · biomérieux s.a. business segments
About Stock Overview & Key Data
bioMérieux S.A. (BMXMF) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on OTC since Sep 21, 2017. As of the latest trading session, BMXMF stock price is $84.00, with a market capitalization of $9.9B. The stock has returned -38.24% over the past 12 months and -35.01% year-to-date.
According to 5 Wall Street analysts, the consensus rating for bioMérieux S.A. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, bioMérieux S.A. reported revenue of $4.1B and net income of $397.4M. For detailed data — including bioMérieux S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, bioMérieux S.A. (BMXMF) stock price is $84.00. The stock is traded on OTC under the ticker symbol BMXMF. The 52-week range is $77.38 – $152.00.